Microsoft word - wfyi public broadcasting to award speaking of women.doc
WFYI Public Broadcasting to Award Speaking of Women’s Health® Community Investments Grants to Girls Incorporated of
Indianapolis and the Hendricks County Community Foundation
FOR IMMEDIATE RELEASE: September 19, 2008
Contact: Lori Plummer (317) 614-0462 - firstname.lastname@example.org
As part of WFYI Public Broadcasting’s on-going commitment toward promoting the health and wel -being of Hoosier women, the station
is recognizing the efforts of two local organizations that are making a big difference in the lives of Central Indiana women and their
families. The Hendricks County Community Foundation
and Girls Incorporated of Indianapolis
have been selected as the co-
recipients of WFYI’s 2008 Speaking of Women’s Health
® community investment grants. Each organization will be awarded a $5,000
community investment grant in support of their women’s health initiatives.
The Hendricks County Community Foundation provides donors with flexible, efficient and tax-effective ways to ensure their charitable
giving achieves the greatest possible impact. WFYI’s Community Investment Grant will aid the Foundation’s “Habit of the Heart Fund,”
which helps to meet the emergency needs of Hendricks County youth and women.
Since 1969, Girls Incorporated of Indianapolis has been inspiring all girls to be strong, smart and bold. The organization partners with
schools and community organizations to deliver educational programs to girls (ages 6-18). WFYI’s Community Investment Grant will
be used by Girls Incorporated of Indianapolis to help Central Indiana girls learn about Redefining Beauty, Medial Literacy®, and Living
Safe and Strong®.
WFYI’s 2008 Community Investment Grants were awarded during the 11th annual Speaking of Women’s Health
® Conference on Friday,
September 12, at the Indiana Convention Center. Conference proceeds will benefit WFYI Public Broadcasting’s mission to enrich the
Central Indiana community through its programming and educational outreach services. Additional information is available by visiting wfyi.org
About Speaking of Women’s Health
Speaking of Women's Health's mission is to "educate women to make informed decisions about health, well-being and personal safety for
themselves and their families." The 501(c)(3) nonprofit organization educates and empowers women nationwide through more than 50 conferences
and events across the country; its health programs, Universal Sisters and Hablando de la Salud de la Mujer; community events and education
centers with free health brochures in Wal-Mart stores nationwide; a free quarterly newsletter, a Web site and a television show, "Lifetime's Speaking
of Women's Health."
WFYI’s Speaking of Women's Health's conference is presented by St. Vincent Women's Hospital, with additional support from The Care Group, St.
Vincent Heart Center, Nightingale Home Healthcare, Fifth Third Bank and Anthem.
Speaking of Women's Health is supported by National Sponsors Wal-Mart, Lifetime, Tylenol, Zyrtec, Kellogg's, L'Oréal Paris, Maybelline New York,
Garnier, Cadbury Schweppes Americas Beverages, Kellogg’s Snacks, Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18)
Vaccine, Recombinant], Slim-Fast, Promise Activ, Vaseline, Degree, Kleenex, Huggies, Kotex, Dove Chocolate, Meredith Corporation, Stryker, One
A Day and Citracal.
SAFETY DATA SHEET 1 - IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Identification of the substance or preparation: Company/undertaking identification: Registered company name: MOTUL TECH. Address: Chemin du Corps de Garde.77360.VAIRES SUR MARNE.FRANCE. Telephone: 184.108.40.206.86.00. Fax: 220.127.116.11.86.25. Email: email@example.com Emergency telephone: +44
FOR IMMEDIATE RELEASE Transport Announces Agreement with Glaxosmithkline for European Rights to a Device/Drug Combination System for High-Potency Delivery of Acyclovir Framingham, MA and Philadelphia, PA, January 27, 2005 – Transport Pharmaceuticals, Inc. (Transport) announced today that GlaxoSmithKline PLC (GSK) has signed a license and collaboration agreement for Transpor